Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|September 1, 2020
Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque PsoriasisWangda Zhou, Chuanpu Hu, Yaowei Zhu, et al.Acta Biomaterialia|April 22, 2023
Donor-acceptor-donor small molecules for fluorescence/photoacoustic imaging and integrated photothermal therapyChang Wang, Fang Wang, Wentao Zou, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 31, 2021
A modular ROS-responsive platform co-delivered by 10-hydroxycamptothecin and dexamethasone for cancer treatmentQingye Meng, Hao Hu, Xiaodong Jing, et al.Analytical Chemistry|November 26, 2024
Regulating Electron Acceptor Unit to Construct Conjugated Polymer Probe for Raman Imaging of Tumor and Sentinel Lymph NodesYing Bao, Yaowei Zhu, Chuanyu He, et al.Journal of Clinical Pharmacology|January 18, 2018
Population Pharmacokinetic Modeling of Guselkumab, a Human IgG1λ Monoclonal Antibody Targeting IL-23, in Patients with Moderate to Severe Plaque PsoriasisZhenling Yao, Chuanpu Hu, Yaowei Zhu, et al.Clinical and Translational Science|May 15, 2020
Evaluating Potential Disease-Mediated Protein-Drug Interactions in Patients With Moderate-to-Severe Plaque Psoriasis Receiving Subcutaneous GuselkumabYaowei Zhu, Yan Xu, Yanli Zhuang, et al.Journal of the American Academy of Dermatology|July 6, 2010
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendationsMark Lebwohl, Newman Yeilding, Philippe Szapary, et al.Journal of Clinical Pharmacology|January 31, 2009
Population pharmacokinetic modeling of ustekinumab, a human monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque psoriasisYaowei Zhu, Chuanpu Hu, Ming Lu, et al.Clinical Drug Investigation|March 21, 2013
Comparison of the pharmacokinetics of subcutaneous ustekinumab between Chinese and non-Chinese healthy male subjects across two Phase 1 studiesYaowei Zhu, Qingmin Wang, Bart Frederick, et al.CPT: Pharmacometrics & Systems Pharmacology|September 17, 2025
Nipocalimab Dose Selection in Generalized Myasthenia GravisBelén Valenzuela, Martine Neyens, Yaowei Zhu, et al.Pageof 3